BURCU GUL WEINER
Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology BOSTON, MA NPI 1811242985
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology MA Amgen Inc. All categories
General Payments — all program years on this page
$748.26
- Category: General Payments
- Program years: PY2022–2024
- Record count: 33
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $196.77 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $196.77 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $41.48 | 2 |
| MEDLINE INDUSTRIES LP | $35.63 | 1 |
| PFIZER INC. | $32.94 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $29.33 | 1 |
| Kiniksa Pharmaceuticals International, plc | $22.28 | 1 |
| Merck Sharp & Dohme Corporation | $21.17 | 1 |
| Terumo Medical Corporation | $13.94 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086799425 | Novartis Pharmaceuticals Corporation | $29.33 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111590872 | Amgen Inc. | $20.72 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117569327 | Amgen Inc. | $20.76 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131718916 | PFIZER INC. | $32.94 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141752158 | Merck Sharp & Dohme LLC | $21.17 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144136390 | Medline Industries LP | $35.63 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151763441 | Terumo Medical Corporation | $13.94 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154857181 | Kiniksa Pharmaceuticals International, plc | $22.28 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.